Designation
Andrew G. Lee, M.D. is chair of the Department of Ophthalmology at The Methodist Hospital in Houston, Texas and is Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medical College. He is adjunct professor of Ophthalmology at Baylor College of Medicine and the University of Iowa and Clinical Professor at the University of Texas Medical Branch in Galveston, Texas. Dr Lee serves on the national and international Editorial Board of 12 journals including the American Journal of Ophthalmology, the Canadian Journal of Ophthalmology, the Japanese Journal of Ophthalmology, the Journal of Neuro-ophthalmology, and Eye and is the editor in chief of the Journal of Academic Ophthalmology. He has published over 300 peer-reviewed articles, 40 book chapters, and eight full textbooks in ophthalmology. He has been the invited speaker at over 35o national and international eye meetings and has delivered 12 named lectures. He has a special interest in resident education and enjoys teaching about teaching in ophthalmology.
He is a Consultant Neurologist and Director of the EMG Lab at the Montreal neurological Institute.
Apart from his administrative duties, the major part of his time is devoted for teaching at the Montreal Neurological Hospital. He organises the Neurology rotation of the medical students and is involved in the daily clinical teaching in the EMG laboratory and in the weekly discussion in the Neurology rounds held at MNH.
He has received the Neurology Teaching Award of the McGill Neurology training programme three times and also received Penfield award in 1982. His special interest is in the field of Neuromuscular diseases and the use of Botulinum toxin in Neurological diseases.
Dr. Philip Schauer is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, Chief of Minimally Invasive General Surgery and Director of the Cleveland Clinic Bariatric and Metabolic Institute (BMI). He is past president of the American Society for Metabolic & Bariatric Surgery (ASMBS). He is co-chair of Obesity Week, the worlds largest annual meeting devoted to the science and treatment of Obesity starting November 2013.
After receiving his medical degree from the Baylor College of Medicine, Dr. Schauer completed his residency in surgery at The University of Texas, where he served as chief resident of general surgery. He then completed his fellowship in laparoscopic surgery at Duke University Medical Center. Prior to joining The Cleveland Clinic in 2004, Dr. Schauer served as director of endoscopic surgery, director of bariatric surgery and Director of the Mark Ravitch/Leon Hirsch Center for Minimally Invasive Surgery at the University of Pittsburgh Medical Center.
Dr. Schauer's clinical interests include surgery for severe obesity, minimally invasive surgery (laparoscopic), and gastrointestinal surgery. He has performed more than 5000 operations for severe obesity. His research interests include the pathophysiology of obesity and related diseases, physiologic effects of laparoscopic surgery on postoperative injury and recovery, and outcomes of laparoscopic management of obesity, gastrointestinal diseases, and hernias. He has also participated in the development of new minimally invasive, endoscopic, and laparoscopic operations. New concepts in surgical training and education have been a major focus of his educational interests.
He has authored more than 200 scientific papers, editorials, textbook chapters, and video productions. He is editor of the textbook Minimally Invasive Bariatric Surgery. He has been an invited speaker for more than 100 regional, national and international lectures on the subject of obesity surgery and laparoscopic surgery. He is principal investigator of the STAMPEDE trail comparing medical and surgical treatment of diabetes and 2 NIH funded studies evaluating surgical treatment of diabetes and obesity. He is past chairman of the research and training and credentialing committees of ASMBS. He is current chairman of the Bariatric Surgery Section of the Obesity Society. He has been on the board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons. He is also a member of International Federation of Surgery for Obesity, the American Surgical Association, the Society of University Surgeons, the Society of Surgery of the Alimentary Tract, Central Surgical Society, and the Society of Clinical Surgery. He is a member of the Board of Governors of the Fellowship Council and past member of the American Board of Surgery Advisory Council. He is on the editorial board of Surgery for Obesity and Related Diseases and Obesity Surgery as well as 3 other medical journals. He has been director of more than 100 courses and workshops on advanced laparoscopic surgery and has trained more than 40 fellows in advanced laparoscopic and bariatric surgery.
2009-present : Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Non-Peer Reviewed Articles (Reviews and Technology Assessments)
Uematsu S, Lesser R, Fisher R, Krauss G, Hart J, Vining EP, Freeman J, Gordon B. Resection of the epileptogenic area in critical cortex with the aid of a subdural electrode grid. Proceedings of the Xth Meeting of the World Society for Stereotactic and Functional Neurosurgery, Maebashi, Japan, October 1989, Stereotact Funct Neurosurg 1990;54&55:34-45.
Krauss GL, Fisher RS. The EEG in alcoholism. American Journal of EEG Technology, 1992;32:118-126
Fisher RS, Krauss GL, Ramsay E, Laxer K, Gates J. AAN Technology Assessment Review Assessment: vagus nerve stimulation for epilepsy. Neurology, 1997;49:293-297. 4.
Krauss GL, Mathews GC. Simillarities in mechanisms and treatment for epileptic and nonepileptic myoclonus. Epilepsy Currents. 2003;3(1):19-22.
Krauss GL. Current understanding of delayed anticonvulsant hypersensitivity reactions. Epilepsy Currents, 2006. 6, 33-37.
Krauss GL. Cognitive Activation of "Hyperexcitable Cortex" in JME: Can It Trigger Seizures? Epilepsy Curr. 2011 Nov;11(6):184-5.
Krauss GL, Edwards HB, Lin B. Lacosamide for the treatment of epilepsy. Ann Med. 2012 Mar 1
Krauss GL. Which Hippocampal Sclerosis is Imaged With 7-T MRI? Epilepsy Curr. 2012;12(3):99-100.
Bateman LM, Begley CE, Ben-Menachem E, Berg AT, Berkovic SF, Cascino GD, Drazkowski J, Edwards JC, Engel J Jr, French JA, Gilliam FD, Hoerth MT, Jehi LE, Kanner AM, Krauss GL, Labiner DM, Loddenkemper T, Luders HO, McKhann GM 2nd, McLachlan R, Modi A, Pennell PB, Shafer PO, Sirven JI, Stern JM, Szaflarski JP, Theodore WH. Overcoming barriers to successful epilepsy management. Epilepsy Curr.2012;(4):158-60.
Head, Division of Neurology, UBC & Vancouver Hospital, 2010-
Director, Pacific Parkinson’s Research Centre and National Parkinson Foundation Centre of Excellence at UBC, 2001-present;
Canada Research Chair (Tier I) in Parkinson’s Disease, 2000-present.
Director, CIHR Team in Parkinson’s Disease, 2001-2011 and MSFHR Research Unit in Parkinson’s Disease and Monoaminergic Function in the Central Nervous System, 2006-2010.
Professor, UBC, 1996-present;
>245 papers & book chapters
BA University of Minnesota, Minneapolis Major: Psychology, 8/81-12/86
MD University of Minnesota School of Medicine Minneapolis, 8/87-6/91
MPH University of Washington, Seattle Major: Epidemiology: 9/95-6/98
Internship University of Washington, SeattleDepartment of Medicine, 7/91-6/92
Neurology Residency University of Washington, Seattle Department of Medicine Division of Neurology, 7/92-6/95
Infectious Diseases University of Washington, Seattle Fellowship Department of Medicine: 7/95-6/98
Teaching Scholars University of Washington, Seattle Certificate Program Department of Biomedical Education and Informatics: 9/02-7/03
2004 to Present Diplomate, American Board of Psychiatry and Neurology #52606
1991-present Washington State #MD00031503
Editorial Board:
Ad hoc reviewer: Clin Infect Diseases, Trans Royal Soc Trop Med Hygiene, J Infect Diseases, Sexually Transmitted Diseases, Acta Neuropathologica, Lancet Neurology, Amer Soc Trop Med Hygiene, Int J of Infect Diseases, Acta Parasitologica, The Neurologist, Neurology, Pediatric Infectious Disease Journal, Journal of the Neurological Sciences, PLoS Neglected Tropical Diseases, Pathogens and Global Health, European Journal of Neurology, Lancet Infectious Diseases
Area of Practice
Otology, Neurotology, Cochlear Implants and Skull Base Surgery
University Appointments:
Professor, Dept. of Surgery, Division of Otolaryngology, Dalhousie University, Halifax, Nova Scotia, Canada. Jan 1st 2001-
Head, Division of Otolaryngology-Head and Neck Surgery, Dalhousie University, Halifax, NS, Canada April 1st 2013-
Acting Head, Division of Otolaryngology-Head and Neck Surgery, Dalhousie University, Halifax, NS, Canada Sept 1st 2009- Feb 28th 2013
Professor
Director:
QEII and IWK Health Sciences Centres, Halifax, Nova Scotia, Canada. Jan 1st 2001-
Associate Professor, Dept. of Surgery, Dalhousie University Halifax, Nova Scotia 2001-2005
Assistant Professor, Dept. of Otolaryngology, University of Toronto,Toronto, Ontario, Canada. Sept. 1996 – Dec. 2000
Staff Otolaryngologist (Otology/Neurotology) Dept. of Otolaryngology, The Toronto Hospital-University Health Network Toronto, Ontario, Canada. Sept. 1996 – Dec. 2000
Bachelor of Medicine and Surgery (M.B., Ch.B.) July 1985 University of Manchester, Manchester, England, UK
Bachelor of Science (B.Sc Hons) Physiology July 1982 University of Manchester, Manchester, England, UK
Master of Science (M.Sc.) Vestibular Neuroscience June 1991 Institute of Medical Science, University of Toronto, Ontario, Canada Thesis: The activity of Burst Neurons in rhesus monkey brainstem neurons during active head movements: integration with the vestibulo-ocular reflex
Fellow of the Royal College of Surgeons of Canada (FRCSC) (Otolaryngology) Sept. 1995 Royal College of Physicians and Surgeons of Canada
Board Certification, American Board of Otolaryngology June 1996
Exams:
Professor of Neurology, University of California, San Francisco, San Francisco CA
Place of birth: Sydney, Australia
Professor of Neurology
University of British Columbia
Vancouver, Canada
Dr. Teal is the Sauder Family and Heart and Stroke Foundation Professor of Clinical Stroke Neurology, University of British Columbia. Dr. Teal is the Director of the Vancouver Stroke Program at the Center for Stroke and Cerebrovascular Diseases and is on active staff at the Vancouver General Hospital and Health Sciences Centre and is on the consulting staff at BC Children’s Hospital for the assessment of pediatric stroke patients.
Dr. Teal has participated in the in the development of published guidelines for the prevention and treatment of stroke as well as numerous scientific publications and chapters.
Dr. Teal’s primary clinical and research interests are stroke prevention and the treatment of acute stroke. Dr. Teal has participated in over 100 clinical research trials testing new stroke therapies including participation in the early trials of intravenous and intra-arterial thrombolytic therapy for acute stroke. Dr. Teal has a longstanding interest in antithrombotic therapies for stroke prevention.
Dr. Teal has received several awards and recognitions for teaching and education.
Raed Alroughani received a degree in medicine from Charles University. He finished his neurology residency from the University of British Columbia and obtained the neurology certification from the Royal College of Physicians & Surgeon (Canada). He then finished a fellowship in demyelinating disorders at the University of British Columbia. He worked as attending neurologist at the Royal Columbian Hospital (Canada), after which he joined the division of neurology at Amiri hospital (Kuwait). He established the first multi-disciplinary MS clinic at Dasman Research Institute in 2011. He currently serves as a director of MS clinic in Dasman Research institute and as a head of MS clinic at Ibn-Sina hospital.
Dr Alroughani’s fields of interest are principally directed towards the epidemiology and therapeutics of multiple sclerosis. He established the first national MS registry in Kuwait. He currently serves in the scientific leadership group of MS Base, which represents the largest international MS database involving more than 60 countries. He published many key papers on the natural history of MS and use of disease modifying therapies in Kuwait.
Dr Alroughani served as a member of the joint ethical committee formed by Kuwait University and Ministry of Health. He is the past treasurer of the Kuwait Neurological Society. He currently sits on the executive boards of various scientific associations, steering committees and advisory boards, mainly in the field of MS.
Stanley Fahn, MD, is the H. Houston Merritt Professor of Neurology and Director of the Center for Parkinson’s Disease and Other Movement Disorders at Columbia University in New York City. His major interest has been in experimental therapeutics, and has helped organize several trials for the Parkinson Study Group (PSG), including the ELLDOPA trial. He helped create the UPDRS, the Fahn-Marsden Dystonia Rating Scale, and the Tremor Rating Scale. He co-founded the PSG, the Movement Disorder Society, the journal Movement Disorders, the World Parkinson Congresses (held in 2006 and 2010 and to be held in 2013), and most recently the matching plan for movement disorder fellowship programs. Another notable trial was the first controlled surgical trial for fetal tissue transplantation for patients with advanced PD.
Dr. Fahn has served as President of the American Academy of Neurology (AAN) and has twice served as chairman of the Advisory Committee on Peripheral and Central Nervous System Drugs for the Food and Drug Administration. The AAN honored Dr. Fahn with the Wartenberg Award for outstanding clinical research in 1986, the first Movement Disorder Prize for outstanding contributions in this field in 1997, and their A. B. Baker Award for outstanding educator in neurology in 1996. In 2007, he received the James Parkinson Medal, awarded once every 10 years by the Parkinson’s Disease Foundation. In 2002, Dr. Fahn was elected a member of the Institute of Medicine of the US National Academies.
He has been engaged in describing psychogenic movement disorders since the early 1980’s and has developed an approach to diagnosing, explaining to the patients their diagnosis, and treating this condition.
Dr. Virginia Devonshire is an Assistant Clinical Professor in the Division of Neurology at the University of British Columbia (UBC). She obtained her undergraduate degree in Honors Neuropsychology at the University of Alberta and medical degree at the University of Calgary. She then completed a Neurology Residency at UBC as well as a Fellowship in Multiple Sclerosis at the world renowned UBC MS Clinic. She served as the Director for one of the world's largest MS Databases, and published many key papers on the natural history of MS. She became the Director of the UBC MS Clinic in 2006. She has extensive involvement in clinical trial research and has been Principle Investigator in many of the pivotal trials. She was honored with the MS Society's National Award of Merit in 2008. In addition to her work in MS, she is involved in the teaching Fellows, residents and students at UBC. She speaks Nationally and Internationally on topics in MS
Personal Statement
The goal of this proposed research is to investigate the longitudinal clinical course and pathogenic basis of rare CNS autoimmune diseases such as neuromyelitis optica, transverse myelitis, acute disseminated encephalomyelitis, and autoimmune encephalitides. I have extensive experience investigating the clinical characterization, natural history, pathogenesis, and treatment of these diseases, most notably identifying the first replicated serum biomarker (aquaporin-4 antibodies) for any CNS inflammatory demyelinating disease (neuromyelitis optica; NMO) and subsequently integrating it into validated diagnostic criteria. My Mayo Clinic colleagues and I have used this biomarker to define an expanded spectrum of NMO disorders, leading to novel and successful therapeutic strategies. The challenges inherent in rare disease research may be overcome with dedicated, multicenter collaborative efforts that integrate longitudinal clinical care with biomarker and outcomes research. The current application represents a logical extension of my prior research by establishing a network of centers and co-investigators that share these common overall goals but who have complementary expertise in epidemiology, biomarker evaluation, and T cell biology.
Positions and Honors
Other Experience and Professional Memberships
Honors
Selected Peer-reviewed Publications (Selected from >135 peer-reviewed publications)
Most relevant to the current application
Additional recent publications of importance to the field (in chronological order)